Tekla Capital Management LLC Milestone Pharmaceuticals Inc. Transaction History

Tekla Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$5.79 - $8.85 $1.47 Million - $2.24 Million	-253,610 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.57 - $7.66 $224,471 - $308,698	40,300 Added 18.89%	253,610 $1.7 Million
Q1 2020 May 14, 2020	SELL	$1.7 - $22.5 $906,683 - $12 Million	-533,343 Reduced 71.43%	213,310 $392,000
Q4 2019 Feb 13, 2020	BUY	$15.4 - $21.9 $10.8 Million - $15.3 Million	699,713 Added 1490.65%	746,653 $12 Million
Q3 2019 Nov 13, 2019	SELL	$15.67 - $25.96 $47,950 - $79,437	-3,060 Reduced 6.12%	46,940 $812,000
Q2 2019 Aug 14, 2019	BUY	$15.37 - $27.15 $768,500 - $1.36 Million	50,000 New	50,000 $1.36 Million

28.6M

200

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $51M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.